|
VOLUME 33: NO. 7 JULY 2006
Editorials
Improving Outcomes in Rheumatoid Arthritis:
What Determines Decisions to Change Ineffective Therapy?
 T. Sokka, H. Mäkinen.........1213
The Predictive Power of Anti-Cyclic Citrullinated Peptide Antibodies: Window into Understanding Gene/Environment/Immunity Interactions
 W. Lee, M.H. Weisman.........1216
Further Evidence for Insufficient Hypothalamic-Pituitary-Glandular Axes in Polymyalgia Rheumatica
 R.H. Straub, M. Cutolo.........1219
Outcome in Small-Vessel Systemic Vasculitis
 R.A. Luqmani, O. Flossmann.........1224
Towards International Guidelines for the
Management of Psoriatic Arthritis
 D.D. Gladman, P.J. Mease.........1228
Articles
COX-2 Genotype and RA
 K.H. Lee, H-S. Kim, A. El-Sohemy, M.C. Cornelis,
W-S. Uhm, S-C. Bae.........1231
SLC22A4, RUNX1, and SUMO4 Polymorphisms
Are Not Associated with RA: A Case-Control
Study in a Spanish Population

G. Orozco, E. Sánchez, M.A. González-Gay, et al.........1235
The Role of Anti-CCP Antibodies in Predicting Progression of Palindromic Rheumatism to RA

A.S. Russell, A. Devani, W.P. Maksymowych.........1240
Which Variables Best Predict Change in
RA Therapy in Daily Clinical Practice?

M. Soubrier, D. Zerkak, L. Gossec, X. Ayral,
C. Roux, M. Dougados .........1243
Factors Associated with Permanent Work
Disability in Mexican Patients with RA.
A Case-Control Study

J. Morales-Romero, L. Gonzalez-Lopez, A. Celis,
B.E. Rodríguez-Arreola, C.E. Cabrera-Pivaral,
J.I. Gamez-Nava .........1247
ILD in Patients with RA: Comparison with Cryptogenic Fibrosing Alveolitis over 5 Years

A.B. Rajasekaran, D. Shovlin, V. Saravanan,
P. Lord, C. Kelly.........1250
The Frequency and Distribution of Minocycline Induced Hyperpigmentation in a RA Population

G. Roberts, H.A. Capell .........1254
Most Rheumatologists Are Conservative in Active
RA Despite MTX Therapy: Results of the PRISME Survey

A. Saraux, V. Devauchelle-Pensec, L. Engerran,
R-M. Flipo .........1258
Cost-Effectiveness Analysis of MTHFR
Polymorphism Screening by PCR in Korean
Patients with RA Receiving MTX

S-K. Kim, J-B. Jun, A. El-Sohemy, S-C. Bae.........1266
Dietary Caffeine Intake Does Not Affect MTX
Efficacy in Patients with RA

E. Benito-Garcia, J.E. Heller, L.B. Chibnik, et al.........1275
Dimensions of Fatigue in SLE: Relationship to
Disease Status and Behavioral and Psychosocial Factors

D. Da Costa, M. Dritsa, S. Bernatsky, et al .........1282
Comparative Analysis of Autoantibodies Against
a-Fodrin in Serum, Tear Fluid, and Saliva from
Patients with SS

S. Yavuz, E. Toker, M. Bicakcigil, G. Mumcu,
S. Cakir .........1289
Low Serum Levels of DHEAS in Untreated
Polymyalgia Rheumatica/Giant Cell Arteritis

J. Narváez, B. Bernad, C. Diaz Torné, et al.........1293
Outcome and Prognostic Factors During the Course of Primary Small-Vessel Vasculitides

L. Pavone, C. Grasselli, E. Chierici, et al .........1299
Management of Infusion Reactions to Infliximab in Patients with RA or SpA: Experience from an Immunotherapy Unit of Rheumatology

T. Lequerré, O. Vittecoq, N. Klemmer, et al .........1307
Nail and Distal Interphalangeal Joint in PsA

R. Scarpa, E. Soscia, R. Peluso, et al.........1315
Prostaglandin Production by Human Osteoclasts in Culture

J.A. Hackett, H. Allard-Chamard, P. Sarrazin, et al .........1320
Short-term Gene Expression Changes in Cartilage Explants Stimulated with IL-1ß plus Glucosamine
and Chondroitin Sulfate

P-S. Chan, J.P. Caron, M.W. Orth.........1329
Recent Diuretic Use and the Risk of Recurrent Gout Attacks: The Online Case-Crossover Gout Study

D.J. Hunter, M. York, C.E. Chaisson, R. Woods,
J. Niu, Y. Zhang.........1341
The Prevalence of Hyperuricemia in a Population
of the Coastal City of Qingdao, China

H. Nan, Q. Qiao, Y. Dong, et al.........1346
Systematic Review of the Efficacy and Safety of
Shock Wave Therapy for Lateral Elbow Pain

R. Buchbinder, S.E. Green, J.M. Youd,
W.J.J. Assendelft, L. Barnsley, N. Smidt.........1351
Chemotherapy-Related Arthropathy

M-J. Kim, Y-M. Ye, H-S. Park, C-H. Suh.........1364
Pediatric Rheumatology
Functioning and Preferences for Improvement of
Health Among Patients with JIA in Early Adulthood Using the WHO ICF Model

M. Arkela-Kautiainen, J. Haapasaari,
H. Kautiainen, et al .........1369
Epidemiology of JIA in Alsace, France

S. Danner, C. Sordet, J. Terzic, et al .........1377
Radiographic and Clinical Outcome in Early JRA and JSpA: A 3-Year Prospective Study

A.M. Selvaag, B. Flatø, K. Dale, et al .........1382
Enzyme Elevation in Patients with JDM and Steroid Myopathy

M.Y. Naim, A.M. Reed .........1392
Epitope Mapping of Anti-a-Fodrin Autoantibody in Juvenile SS: Difference in Major Epitopes Between Primary and Secondary Cases

R. Shiari, I. Kobayashi, N. Toita, et al.........1395
Tribute and Reflection William Watson Buchanan,
MD, FRCP, FRCPC, 1930-2006

P. Lee.........1401
Meeting Report Cardiovascular Effects of Selective COX-2 Inhibition: Is There a Class Effect?
The International COX-2 Study Group

L.J. Crofford, M.D. Breyer, C.V. Strand, et al .........1403
Case Reports
Haverhill Fever with Spine Involvement

H. Abdulaziz, C. Touchie, B. Toye, J. Karsh.........1409
Anti-TNF-a-Induced Psoriasis

I. Sari, S. Akar, M. Birlik, B. Sis, F. Onen, N. Akkoc.........1411
Images in Rheumatology
Clinical Images: Bazin's Disease (Erythema Induratum)

M. Al-Mashaleh, D. Packham, N. Manolios.........1415
Spontaneous Osteonecrosis of the Knee

J.Y. Kim, D.R. Finger.........1416
Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): Systematic Review of Treatments for PsA
Systematic Review of Treatments for PsA:
An Evidence Based Approach and Basis for
Treatment Guidelines

A.F. Kavanaugh, C.T. Ritchlin,
the GRAPPA Treatment Guideline Committee.........1417
Therapies for Peripheral Joint Disease in PsA

E.R. Soriano, N.J. McHugh.........1422
Therapies for Axial Disease in PsA

P. Nash.........1431
Therapies for Psoriatic Enthesopathy

C.T. Ritchlin.........1435
Therapies for Dactylitis in PsA

P.S. Helliwell.........1439
Conventional Systemic Agents for Psoriasis

B.E. Strober, K. Siu, K. Menon.........1442
Biologic Therapies for Psoriasis

W-H. Boehncke, J. Prinz, A.B. Gottlieb.........1447
Therapies for Psoriatic Nail Disease

S. Cassell, A.F. Kavanaugh.........1452
Letters
Demyelinating Disease in a Patient with PsA and Family History of Multiple Sclerosis Treated with Infliximab
T. Ruiz-Jimeno, A. Carvajal, C. Mata,
E. Aurrecoechea.........1457
Giant Cell Arteritis -- The Methotrexate Debate Revisited
D. Rimar, M. Rozenbaum, D. Zisman, et al.........1458
Book Reviews
A Primer on Musculoskeletal Examination.........1459
Occupational Musculoskeletal Disorders.........1460
Correction.........1460
Meetings in Rheumatology
|